Fortress Biotech, Inc. (NASDAQ:FBIOP) Short Interest Down 56.6% in June

Fortress Biotech, Inc. (NASDAQ:FBIOP) was the target of a large drop in short interest in the month of June. As of June 15th, there was short interest totaling 4,938 shares, a drop of 56.6% from the May 31st total of 11,366 shares. Based on an average daily volume of 41,576 shares, the days-to-cover ratio is currently 0.1 days.

Fortress Biotech Trading Up 0.3%

FBIOP opened at $20.11 on Monday. The firm has a fifty day moving average price of $17.16 and a 200 day moving average price of $13.76. Fortress Biotech has a 1 year low of $6.27 and a 1 year high of $21.43.

Fortress Biotech Company Profile

Fortress Biotech, Inc (NASDAQ: FBIOP) is a biopharmaceutical company that acquires, develops and commercializes innovative therapeutics for the treatment of patients with serious diseases. Operating as a biotech accelerator, Fortress Biotech partners with experienced management teams to advance products from early-stage discovery through regulatory approval and commercial launch. Its diversified portfolio spans multiple therapeutic areas, including oncology, rare diseases, dermatology, ophthalmology and neuromuscular disorders.

The company’s business model centers on establishing and funding product-centric subsidiary companies, each focused on a specific drug candidate or therapy.